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From 2003 to 2005, we prospectively collected 118
isolates of pneumococci belonging to 7 serotypes to inves-
tigate their competence under the influence of the synthet-
ic competence-stimulating peptides. The degree of
competence of the various serotypes differed significantly.
Serotype 6B had the highest competence, followed by
serotypes 14, 19F, 9V, 23F, 3, and 18C. Isolates belonging
to serotype 6B had greater genetic diversity than isolates
belonging to serotype 3, which has high genetic clustering.
Isolates belonging to serotypes 3 and 18C that were 100%
sensitive to penicillin were significantly less competent than
isolates belonging to serotypes 6B, 14, 19F, 9V, and 23F,
which were frequently resistant to penicillin. Under the 7-
valent pneumococcal conjugate vaccine program,
enhanced molecular surveillance of virulent clones with
higher competence to detect serotype switching will
become more important.
S
treptococcus pneumoniae, a leading cause of bac-
teremia, sinusitis, otitis media, bacterial meningitis,
and bacterial pneumonia, causes substantial illness and
death in persons worldwide (1). In recent decades, the
increase of S. pneumoniae strains resistant to β-lactam
antimicrobial drugs and other classes of antimicrobial
drugs has further complicated the treatment of pneumo-
coccal infection (2). Although the current introduction of
conjugate pneumococcal vaccine has successfully reduced
invasive pneumococcal disease caused by the vaccine
serotypes and effectively decreased the spread of antimi-
crobial drug–resistant isolates, pneumococcal infection
remains a major issue, in light of the selective pressure that
has been invoked by vaccination programs (3,4). At least 2
consequences have been noted since the large-scale use of
7-valent conjugate vaccine. First, serotypes not covered by
the conjugate vaccine have increased both in nasopharyn-
geal colonization and clinical illness (serotype replace-
ment) (5,6). Second, serotype switching can occur through
recombination in naturally transformable clones and result
in the acquisition of a nonvaccine capsule (5,7). Therefore,
investigating how competent pneumococci can be for
genetic transformation is useful because this factor plays a
role in the evolution of S. pneumoniae, especially with
respect to virulence and antimicrobial drug resistance (8,9).
The ability of S. pneumoniae to undergo horizontal gene
transfer leads to genetic diversity and helps the organism
adapt to environmental changes. Since the discovery of
competence-stimulating peptide (CSP) by Havarstein et al.,
the detailed mechanism of competence in S. pneumoniae
has gradually been clarified (10). However, few studies
have examined the different competence levels across a
range of clinical isolates (11). Our aims in this study were
to compare competence among clinical isolates of various
serotypes and to increase our understanding of the role of
competence in penicillin-resistant S. pneumoniae.
Materials and Methods
Bacterial Isolates
From January 2003 to December 2005, a total of 118 S.
pneumomiae isolates were prospectively collected for this
study. These isolates were recovered from various clinical
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Taiwan. The samples were collected from areas in which
pneumococcal conjugate vaccine has not been widely
implemented. The hospitals included National Taiwan
University Hospital, Taipei (62 isolates); Taichung
Veterans General Hospital, Taichung (19 isolates);
People’s Republic of China Medical College Hospital,
Taichung (5 isolates); National Cheng-Kung University
Hospital, Tainan (3 isolates); Chang-Gung Memorial
Hospital, Kaohsiung (12 isolates); and Kaohsiung Veterans
General Hospital, Kaohsiung (17 isolates). Among these
isolates, 24 isolates (20.2%) were recovered from normal-
ly sterile body sites (21 isolates from blood, 2 isolates from
pleural fluid, and 1isolate from peritoneal fluid); the rest
were isolated from respiratory tract secretions.
Antimicrobial Drug Susceptibility Testing
The MICs of penicillin for all 118 S. pneumoniae iso-
lates were determined by the agar dilution method and
were interpreted according to the guidelines established by
the Clinical and Laboratory Standards Institute (CLSI; for-
merly the National Committee for Clinical Laboratory
Standards) (12,13). Strains with an MIC <0.06  µg/mL
were defined as susceptible, i.e., penicillin-susceptible S.
pneumoniae (PSSP). Strains with an MIC of 0.12–1
µg/mL were defined as intermediately resistant, i.e., peni-
cillin-intermediate S. pneumoniae (PISP), whereas those
with an MIC ≥2 µg/mL were penicillin-resistant S. pneu-
moniae (PRSP).
Serotyping
The serotypes of isolates were determined by using the
capsular swelling method (Quellung reaction). All antisera
were obtained from the Statens Seruminstitut
(Copenhagen, Denmark).
PFGE Analysis
Serotype 6B, which had the highest competence, and
serotypes 3 and 18C, which had the lowest competence,
were selected for pulsed-field gel electrophoresis (PFGE)
analysis. PFGE was performed according to the method
previously described (14). The DNA was digested with
SmaI. Bands were stained with ethidium bromide and visu-
alized with UV light. PFGE patterns that differed by <3
bands were defined as 1 PFGE type; isolates with the same
PFGE patterns indicated indistinguishable strains, and
those with 2 or 3 different bands indicated closely related
strains (15).
Transformation of S. pneumoniae
All pneumococcal isolates were grown at 35°C in
Todd–Hewitt broth supplemented with 0.5% yeast extract
(THY) in static culture in the presence of 5% CO2.
Bacteria were stored in THY and 10% glycerol.
Transformations were performed as described previously
with modification (8,16). Briefly, early log phase S. pneu-
moniae cultures in THY, pH 6.8 (pH adjusted with HCl),
supplemented with 1 mmol/L CaCl2 and 0.2% bovine
serum albumin (BSA) were diluted 1:10 with THY, pH 8.0
(adjusted with NaOH), supplemented with 1 mmol/L
CaCl2 and 0.2% BSA. Synthetic 100 ng/mL CSP-1 or
CSP-2, in 10 mmol/L glucose and 10% horse serum
(Sigma, Saint Louis, MO, USA) were added followed by
incubation for 15 min at 37°C. Plasmid pDL278, an
Escherichia coli/S. pneumoniae shuttle vector that con-
tained the pVA380–1 basic replicon and the pUC origin of
replication (6,733 bp) was then added (1 µg/mL), and sam-
ples were incubated for 1 h at 35°C under 5% CO2 before
being spread on blood agar plates containing 500 µg/mL
spectinomycin (17). Control experiments were carried out
by using the same protocol without adding pDL278. The
transformation frequencies were expressed as the log10
value of the percentage of transformed cells. Isolates with
a log10 value of transformation frequencies less than −10
were defined as noncompetent isolates, and those larger
than −4 were defined as high competent isolates. (Because
the report of transformation frequency in S. pneumoniae is
limited, we chose −4 as the cutoff point of high frequency
based on the experience of transformation frequency in
Helicobacter pylori. [18].)
Statistical Analysis
After log transformation, the data for competence
(transformation frequency) exhibited a normal distribution
(p>0.05). Thus, differences of competence between multi-
ple serotypes and groups were tested by using 1-way
analysis of variance with the Bonferroni method for post-
hoc multiple comparisons. The Student t  test was used
when competence were compared between 2 groups.
Linear regression was used to detect the trend of compe-
tence among the PSSP, PISP, and PRSP groups. The rela-
tionship of penicillin resistance with competence was
analyzed in a logistic regression model which controlled
for serotypes. χ2 test or Fisher exact test was used for cat-
egorical variables to test significance between groups.
Correlations between competence induced by CSP-1 and
CSP-2 in each serotype were determined by Pearson’s cor-
relation coefficient. A p value < 0.05 was considered sig-
nificant. All probabilities were 2-tailed. Data were
reported as mean ± standard error of the mean (SEM)
unless otherwise indicated.
Results
We found 7 serotypes among the 118 isolates: 6B (23
strains), 14 (20 strains), 23F (26 strains), 9V (14 strains),
19F (21 strains), 3 (11 strains), and 18C (3 strains). Of the
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intermediately resistant and 19.5% were highly resistant.
Competence, Serotype, and 
Genetic Heterogeneity
Figure 1 shows the log-transformed means (±SEM) of
the transformation frequencies of serotypes 6B, 14, 19F,
9V, 23F, 3, and 18C induced by CSP-1 and CSP-2. In gen-
eral, competence induced by CSP-1 was higher than that
induced by CSP-2, except for serotype 23F. Competence
induced by CSP-1 was positively correlated with compe-
tence induced by CSP-2 (Pearson’s correlation coefficient
0.84, p<0.001). Significant differences of competence
were found among serotypes under induction by either
CSP-1 or CSP-2 (p<0.001). Serotype 6B had the highest
competence, followed by 14, 19F, 9V, 23F, 3, and 18C.
Under the induction of CSP-1, competence in serotype 6B
(−4.1 ± 0.2) was significantly higher than for serotypes 9V
(−6.4 ± 0.4), 23F (−6.8 ± 0.5), 3 (−7.8 ± 0.7) and 18C (−
8.4 ± 1.8); similarly, competence in serotype 14 (−5.4 ±
0.3) was significantly higher than for serotype 3 (p<0.05
by post-hoc analysis). Under the induction of CSP-2, com-
petence in serotype 6B (−5.2 ± 0.3) was significantly high-
er than those in serotypes 23F (−6.7 ± 0.4), 3 (−8.1 ± 0.6),
and 18C (−8.8 ± 1.6). Competence in serotypes 14 (−5.5 ±
0.3) and 19F (−6.2 ± 0.5) was significantly higher than for
serotype 3, and competence in serotype 14 was significant-
ly higher than for serotype 18C (p<0.05 by post-hoc analy-
sis). The 23 isolates expressing serotype 6B displayed a
high level of genetic diversity; this was illustrated by their
division into 10 PFGE patterns (Figure 2). Among them, 1
main PFGE type accounted for 30.4% (7/23) of all isolates
of serotype 6B. These 7 strains were closely related. In
contrast, the 11 isolates expressing serotype 3 were genet-
ically indistinguishable, which showed only 1 PFGE pat-
tern. The result indicated that this serotype was highly
clonal in Taiwan (Figure 2). The 3 isolates expressing
serotype 18C had 2 PFGE types. Twenty-two isolates had
a competence higher than 10−4 under the induction of CSP-
1: 11 isolates of 6B, 4 isolates of 14, 4 isolates of 19F, and
3 isolates of 23F. Under the induction of CSP-1, isolates
belonging to serotypes 6B, 14, 19F, and 23F were signifi-
cantly associated with high competence when compared
with isolates belonging to serotypes 9V, 3, and 18C
(24.4%, 22/90 vs 0%, 0/28; p = 0.002). Six isolates had
competence higher than 10−4 under the induction of CSP-
2: 2 isolates of 6B, 3 isolates of 14, and 1 isolate of 23F.
Under the induction of CSP-2, isolates belonging to
serotypes 6B, 14, 19F, and 23F were not associated with
high competence compared with isolates belonging to
serotypes 9V, 3, and 18C (6.7%, 6/90 vs. 0%, 0/28; p =
0.3). Among all the 118 isolates, 111 (94.1%) became com-
petent after the induction with CSP-1, and 112 (94.9%)
became competent after the induction with CSP-2. Two
isolates of 19F, 1 isolate of 23F, 1 isolate of serotype 18C,
and 2 isolate of serotype 3 were noncompetent with either
CSP-1 or CSP-2.
Competence and Penicillin Resistance
The distributions of PSSP, PISP, and PRSP in each
serotype were significantly different (p = 0.001) (Table).
The proportions of penicillin-susceptibility in serotypes
6B, 14, 19F, 9V and 23F were 8.7%, 35%, 19%, 21.4%,
and 3.8%, respectively. (Table). While in serotypes 3 and
18C, the proportions of penicillin-susceptibility were
100%. Under the induction of either CSP-1 or CSP-2,
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Figure 1. Competence (transformation frequency) induced by
competence-stimulating peptide 1 (CSP-1) and CSP-2 in clinical
isolates.
Figure 2. Pulsed-field gel electrophoresis (PFGE) types of 47 iso-
lates of serotype 6B, serotype 3, and serotype 18C. Numbers in
parentheses indicate the total number of isolates belonging to
each PFGE type. Lane M,  λ ladder; lanes A–J, 10 PFGE types
found among 23 isolates of serotype 6B; lane K, 1 PFGE type
found among 11 isolates of serotype 3; lanes L–M, 2 PFGE types
found among 3 isolates of serotype 18C.isolates belonging to serotypes 3 and 18C that were not
resistant against penicillin were significantly less compe-
tent than isolates belonging to serotypes 6B, 14, 19F, 9V,
and 23F, which were frequently resistant to penicillin
(p<0.001 for CSP-1, p<0.001 for CSP-2 by the Student t
test) (Figure 3). Among all isolates belonging to serotype
6B, 14, 19F, 9V, and 23F, the proportions of PSSP, PISP,
and PRSP were 16.3%, 61.5%, and 22.2%. Competence
between PSSP, PISP, and PRSP was not significantly dif-
ferent (p = 0.2 for CSP-1, p = 0.3 for CSP-2) (Figure 4).
By using the linear regression test to test for trend, compe-
tence was not significantly correlated with increasing peni-
cillin resistance among isolates belonging to serotypes 6B,
14, 19F, 9V, and 23F (p = 0.7 for CSP-1, p = 0.3 for CSP-
2). In a logistic regression model that controlled for
serotypes, competence was not significantly correlated
with penicillin resistance (odds ratio 0.8, p = 0.3, 95% con-
fidence interval [CI] 0.58–1.17 for CSP-1; odds ratio 0.9,
p = 0.4, 95% CI 0.58–1.25 for CSP-2).
Discussion
S. pneumoniae was the first pathogen to demonstrate the
phenomenon of transformation (19). In 1944, Avery et al.
proved that the genetic material in bacterial cells was DNA
by using a transformation model in S. pneumoniae (20).
Natural competence for genetic transformation in S. pneu-
moniae is mediated by a quorum sensing-regulated system.
CSP, a heptadecapeptide pheromone, induces competence
in growing cells at a critical cell density by activating the 2-
component signal transduction system comDE (10).
However, spontaneous competence has been observed only
in some rough laboratory strains. Most clinical encapsulat-
ed isolates do not show competence unless synthetic CSPis
added (11). In this study, we examined the levels of compe-
tence of various clinical isolates with the aid of synthetic
CSP to gain insight into the association between compe-
tence and serotype and penicillin resistance.
Our results showed that different serotypes of S. pneu-
moniae possess different levels of competence. Serotype
6B was the most competent, consistent with our findings
that these strains had high genetic diversity. On the other
hand, serotypes 3 were less competent, consistent with our
findings that these strains had low genetic heterogeneity.
Large amounts of capsular polysaccharide have been
reported to have an inhibitory effect on transformation in
S. pneumoniae (21), and therefore relatively rich amounts
of capsular polysaccharide in serotype 3 and 18C may
block uptake of foreign DNA. Finding extremely low com-
petence in serotype 3 could explain the limited genetic het-
erogeneity in serotype 3, which has also been observed in
Canada, the United Kingdom, and the Netherlands (22).
Serotype 3 was an infrequent pathogen among childhood
pneumococcal diseases before the conjugate pneumococ-
cal vaccination was implemented, even though the
serotype is highly virulent (22,23); however, it is emerging
as an important pathogen after the implementation of con-
jugate pneumococcal vaccination programs (24,25). We
thought that pneumococcal conjugate vaccine could
expand to include serotype 3 because of its high virulence
and limited capacity to facilitate capsular transformation
through horizontal DNA transfer of serotype 3 to better
prevent severe childhood pneumococcal disease.
S. pneumoniae acquires mosaic penicillin-binding pro-
tein (PBP) genes from other Streptococcus species through
a transformation to become penicillin-resistant (26).
Isolates belonging to serotypes 3 and 18C are too low in
competence to have a chance of acquiring the penicillin-
resistance gene. Therefore, serotypes 3 and 18C are rarely
resistant to penicillin (27). Among isolates belonging to
6B, 14, 19F, 9V, and 23F, no significant difference and
association between competence and different level of
penicillin resistance were found. Our explanations based
on this finding are as follows: 1) A high level of compe-
tence is needed for acquiring the penicillin-resistance
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Figure 3. Competence (transformation frequency) induced by
competence-stimulating peptide 1 (CSP-1) and CSP-2 between
isolates belonging to serotypes 6B, 14, 19F, 9V, and 23F, and iso-
lates belonging to serotypes 3 and 18C (*, p<0.05).gene. But, being more competent does not necessarily
result in being penicillin resistant or in having a higher
MIC of penicillin in isolates of serotypes 6B, 14, 19F, 9V,
and 23F. 2) The development of penicillin resistance in S.
pneumoniae is a multistep process. In addition to PBP,
mutation or other non-PBP elements are also important,
especially in the formation of PRSP (28,29). 3) After
acquiring the penicillin-resistance gene, originally compe-
tent isolates might lose genetic components important for
competence during high frequency of genetic transforma-
tion, resulting in isolates that are not competent.
Serotypes with higher competence are more likely to
undergo recombinational exchanges to produce a new
serotype or penicillin-resistant variant (30). The limitation
of our study is examining competence for genetic transfor-
mation in S. pneumoniae by using in vitro assay. We are
not sure if this method can reflect the real transformation
capacity of S. pneumoniae in vivo. In our study, isolates
belonging to serotypes 6B, 14, 19F, and 23F were associ-
ated with high competence, >10−4, a finding that was in
line with earlier studies that observed that serotype 6B, 14,
19F, and 23F frequently showed in vivo capsular transfor-
mation and related to be penicillin-resistant clinical iso-
lates (7,31–34). The only exception is the relatively low
competence of our 14 isolates belonging to serotype 9V, in
which international Spain9V had usually been reported to
have in vivo capsular transformation (35,36). Certain
serotypes that are frequently involved in capsular switch-
ing and penicillin resistance attributable to high compe-
tence should be further studied. To our knowledge, this is
the first investigation into the relationship of competence
and clinical characteristics in S. pneumoniae. After the
introduction of the 7-valent pneumococcal conjugate vac-
cine, particular strains with genetic advantage may change
their capsules from vaccine serotypes to nonvaccine
serotype through capsular transformation (5,7). We
suggest that enhanced surveillance of virulent clone with
higher competence should allow the detection of serotype
switching. This would be valuable for  the long-term effec-
tiveness of the conjugate vaccine.
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